JAGX - Jaguar Animal Health Inc

Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.

52W High

$35.25

52W Low

$1.57

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.60

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

0.05

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.63

EV/Revenue (<3 favorable)

2.94

P/S (TTM) (<3 favorable)

0.33

P/B (<3 favorable)

0.70

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

34.76%

Institutions (25–75% balanced)

0.63%

Shares Outstanding

2,174,800

Float

1,522,800

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

11,810,000

Gross Profit (TTM)

9,670,000

EPS (TTM)

37.53

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-2.69%

ROE (TTM) (>15% strong)

-3.19%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.10

Momentum

Bearish momentum

Value

-0.0673

-0.0807

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025